Logo image of NAYA

NAYA BIOSCIENCES INC (NAYA) Stock Fundamental Analysis

NASDAQ:NAYA - Nasdaq - US44984F4019 - Common Stock - Currency: USD

2.2  +0.17 (+8.37%)

After market: 2.34 +0.14 (+6.36%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NAYA. NAYA was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NAYA have multiple concerns. NAYA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NAYA had negative earnings in the past year.
In the past year NAYA has reported a negative cash flow from operations.
NAYA had negative earnings in each of the past 5 years.
In the past 5 years NAYA reported 4 times negative operating cash flow.
NAYA Yearly Net Income VS EBIT VS OCF VS FCFNAYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

NAYA has a Return On Assets of -43.87%. This is in the lower half of the industry: NAYA underperforms 64.21% of its industry peers.
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROIC N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAYA Yearly ROA, ROE, ROICNAYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

NAYA has a Gross Margin of 42.40%. This is in the lower half of the industry: NAYA underperforms 66.32% of its industry peers.
In the last couple of years the Gross Margin of NAYA has declined.
NAYA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
NAYA Yearly Profit, Operating, Gross MarginsNAYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

NAYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NAYA has been increased compared to 1 year ago.
The number of shares outstanding for NAYA has been increased compared to 5 years ago.
Compared to 1 year ago, NAYA has an improved debt to assets ratio.
NAYA Yearly Shares OutstandingNAYA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NAYA Yearly Total Debt VS Total AssetsNAYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

NAYA has an Altman-Z score of -6.38. This is a bad value and indicates that NAYA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NAYA (-6.38) is worse than 73.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.38
ROIC/WACCN/A
WACC6.25%
NAYA Yearly LT Debt VS Equity VS FCFNAYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

NAYA has a Current Ratio of 0.23. This is a bad value and indicates that NAYA is not financially healthy enough and could expect problems in meeting its short term obligations.
NAYA has a worse Current ratio (0.23) than 95.79% of its industry peers.
A Quick Ratio of 0.20 indicates that NAYA may have some problems paying its short term obligations.
With a Quick ratio value of 0.20, NAYA is not doing good in the industry: 96.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.2
NAYA Yearly Current Assets VS Current LiabilitesNAYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

NAYA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.18%, which is quite impressive.
The Revenue has grown by 224.37% in the past year. This is a very strong growth!
The Revenue has been growing by 43.87% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%

3.2 Future

Based on estimates for the next years, NAYA will show a very negative growth in Earnings Per Share. The EPS will decrease by -100.83% on average per year.
The Revenue is expected to grow by 101.26% on average over the next years. This is a very strong growth
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NAYA Yearly Revenue VS EstimatesNAYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
NAYA Yearly EPS VS EstimatesNAYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAYA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NAYA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAYA Price Earnings VS Forward Price EarningsNAYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAYA Per share dataNAYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

NAYA's earnings are expected to decrease with -100.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAYA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NAYA BIOSCIENCES INC

NASDAQ:NAYA (4/25/2025, 8:25:39 PM)

After market: 2.34 +0.14 (+6.36%)

2.2

+0.17 (+8.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-13 2025-05-13
Inst Owners2.88%
Inst Owner ChangeN/A
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.47M
Analysts82.86
Price Target6.12 (178.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)200%
PT rev (3m)200%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1100%
EPS NY rev (1m)0%
EPS NY rev (3m)-1100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS9.3
BVpS-0.03
TBVpS-14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.4%
FCFM N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.66%
Cap/Sales 2.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.2
Altman-Z -6.38
F-Score3
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)577.95%
Cap/Depr(5y)746.77%
Cap/Sales(3y)8.92%
Cap/Sales(5y)8.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%
EBIT growth 1Y29.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.79%
OCF growth 3YN/A
OCF growth 5YN/A